Skip to main content
Premium Trial:

Request an Annual Quote

Rosetta Announces One-for-Four Reverse Stock Split

Premium

Rosetta Genomics this week announced the effectiveness of a one-for-four reverse stock split, which is intended to boost the per-share trading price of the company's ordinary shares to meet the $1 minimum bid price requirement of the Nasdaq Capital Market.

Earlier this year, Rosetta said that it had regained compliance with the exchange's $2.5 million minimum stockholders' equity requirement, but that it still needed to comply with the minimum bid requirement (GSN 3/10/2011).

The company had until Aug. 8 to do so.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.